NEW YORK (GenomeWeb News) – Roche today reported that full-year 2009 sales of its molecular diagnostic products rose 2 percent to CHF 1.18 billion ($1.11 billion).
The Swiss drugs, diagnostics, and life science research products firm said that its molecular diagnostics' core blood screening and virology segments "delivered a solid single-digit rise in overall sales."